Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type: Relationship with cognitive dysfunction

Yvette I. Sheline*, Karen Miller, Mark E. Bardgett, John G. Csernansky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

The authors sought to determine the relationships between cerebrospinal fluid (CSF) levels of three neurotransmitter monoamine metabolites and cognitive function. CSF was collected from subjects with dementia of the Alzheimer's type ([DAT] n = 28) and control subjects (n = 10) for determination of CSF 5-hydroxindole acetic acid (5-HIAA), 3-methoxy-4- hydroxy-phenylglycol (MHPG), and homovanillic acid (HVA) levels. All subjects underwent systematic assessment to determine cognitive function. Subjects with DAT had higher concentrations of CSF MHPG. In the overall sample, cognitive function was inversely correlated with CSF levels of MHPG but not with 5-HIAA or HVA. Within the DAT sample, these correlations did not achieve significance.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
JournalAmerican Journal of Geriatric Psychiatry
Volume6
Issue number2
DOIs
StatePublished - 1998

Funding

This work was supported by grants to the Alzheimer's Disease Research Center (AG05681 and AG03991) and the General Clinical Research Center (RR00036) , both at Washington University Medical Center, in St. Louis, and by grants from the National Institute of Mental Health to Drs. Sheline (K07 MH01370) and Bardgett (MH01109) and by a grant to Dr. Csernansky from the National Institute on Aging (AG11355) .

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type: Relationship with cognitive dysfunction'. Together they form a unique fingerprint.

Cite this